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Accumulating evidence suggests that p21Cip1 located
in the cytoplasm might play a role in promoting trans-
formation and tumor progression. Here we show that
oncogenic H-RasV12 contributes to the loss of actin
stress fibers by inducing cytoplasmic localization of
p21Cip1, which uncouples Rho-GTP from stress fiber for-
mation by inhibiting Rho kinase (ROCK). Concomitant
with the loss of stress fibers in Ras-transformed cells,
there is a decrease in the phosphorylation level of cofi-
lin, which is indicative of a compromised ROCK/LIMK/
cofilin pathway. Inhibition of MEK in Ras-transformed
NIH3T3 results in restoration of actin stress fibers ac-
companied by a loss of cytoplasmic p21Cip1, and in-
creased phosphorylation of cofilin. Ectopic expression
of cytoplasmic but not nuclear p21Cip1 in Ras-trans-
formed cells was effective in preventing stress fibers
from being restored upon MEK inhibition and inhibited
phosphorylation of cofilin. p21Cip1 was also found to
form a complex with ROCK in Ras-transformed cells in
vivo. Furthermore, inhibition of the PI 3-kinase pathway
resulted in loss of p21Cip1 expression accompanied by
restoration of phosphocofilin, which was not accompa-
nied by stress fiber formation. These results suggest
that restoration of cofilin phosphorylation in Ras-trans-
formed cells is necessary but not sufficient for stress
fiber formation. Our findings define a novel mechanism
for coupling cytoplasmic p21Cip1 to the control of actin
polymerization by compromising the Rho/ROCK/LIMK/
cofilin pathway by oncogenic Ras. These studies suggest
that localization of p21Cip1 to the cytoplasm in trans-
formed cells contributes to pathways that favor not only
cell proliferation, but also cell motility thereby contrib-
uting to invasion and metastasis.
p21Cip1/Waf1 (hereafter referred to as p21) is best known for
its ability to directly block the kinase activities of a broad range
of cyclin/cyclin-dependent kinase (CDK)1 complexes in re-
sponse to anti-mitogenic signals or DNA damage (1–3). Despite
its function as a cell cycle inhibitor, which implies that p21 is a
tumor suppressor, elevated level of p21 in the cytoplasm has
been reported to be critical for promoting cell transformation
and survival (4–8). Strikingly, the level of p21 expression is
highly increased in various human cancers such as breast
cancer, bladder cancer, pancreatic cancer, and glioblastoma
(9–12). It remains unclear how elevated cytoplasmic p21 might
contribute to tumorigenesis. One possibility is that p21 is se-
questered away from the nucleus in transformed cells thereby
preventing it from binding to nuclear cyclin/CDK complexes,
thus allowing sufficient cyclin/CDK activity for cell cycle
progression (13). Alternatively, relocalization of p21 to the
cytoplasm may target cytoplasmic molecules such as apopto-
sis signal-regulating kinase 1 (ASK1) thereby promoting cell
survival (7).
The Rho family of GTPases, Rho, Rac, and Cdc42, regulate
cell morphology, cytokinesis, and cell motility through reorga-
nization of actin filaments (14). The interplay between these
GTPases plays a critical role in the regulation of cell morphol-
ogy and motility. Activation of Rac enhances cell spreading and
migration by stimulation of actin polymerization at the plasma
membrane and promoting lamellipodia formation. By contrast,
Rho stimulates contractility and adhesion by inducing the for-
mation of actin stress fibers and focal adhesions. Rho cycles
between GDP-bound inactive and GTP-bound active forms, and
the GTP-bound form binds to specific targets to exert its bio-
logical functions. Two closely related Rho kinases, ROCK-I and
-II, have been established to be key downstream effectors of
Rho to form stress fibers and focal adhesions (15). Rho kinases
contribute to the increased actin-myosin II-mediated contrac-
tility by directly phosphorylating myosin light chain (MLC) and
negatively regulate myosin light chain phosphatase (MLCP) by
phosphorylating myosin binding subunit (MBS) of MLCP (16,
17). Rho kinases also activate LIM kinase, which subsequently
phosphorylates cofilin and thereby inhibits its actin-depoly-
merizing activity, thus leading to stabilization of actin stress
fibers (18).
Ras (H-Ras, K-Ras, N-Ras) regulates cell growth, differenti-
ation, and cell motility (14). The frequency of Ras mutations is
one of the highest of any gene in human cancers (19). Cells
transformed by oncogenic Ras are characterized not only by
deregulated growth control but also pronounced alterations in
the organization of the actin cytoskeleton and adhesive inter-
actions. Changes in the organization of actin filaments are
highly correlated with anchorage-independent growth and tu-
morigenicity, suggesting a fundamental role for actin fibers in
cell growth control (20–22). We and others (23, 24) have shown
that transformation of fibroblasts cells by oncogenic Ras in-
duces constitutive activation of MEK, which causes disruption
of actin cytoskeleton by inactivating the Rho-ROCK-LIM ki-
nase pathway. The inhibition of Rho-dependent stress fiber
formation contributes to the increased motility of Ras-trans-
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formed fibroblasts (24). However, the mechanism of this inac-
tivation has not been elucidated.
In this study, we show that cytoplasmic p21 plays a critical
role in the morphological and cytoskeletal changes observed in
Ras-transformed fibroblasts. We demonstrate that sustained
activation of both MEK and PI3K effector pathways are neces-
sary for the elevation of p21 protein in the cytoplasm of Ras-
transformed NIH3T3 cells. The cytoplasmic p21 forms a phys-
ical complex with ROCK and inhibits its activity, thereby
contributing to the loss of actin stress fibers by compromising
the ROCK/LIMK/cofilin pathway. Our findings suggest a novel
physiological role for cytoplasmic p21 in remodeling of the actin
cytoskeleton by oncogenic Ras.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents—The mouse monoclonal anti-ROCK-I mAb
(clone 46) and anti-ROCK-II mAb (clone 21) were purchased from
Transduction Laboratories (Lexington, KY). Anti-p21Cip1 mAb and rab-
bit polyclonal antibody detecting cofilin phosphorylated by LIMK at
Ser-3 was from Santa Cruz Biotechnology (Santa Cruz, CA). Mono-
clonal anti-vinculin antibody (hVIN-1) was from Sigma Chemical. The
rabbit polyclonal anti-cofilin was from Cytoskeleton (Denver, CO). The
rabbit anti-ROCK-I pAb was kindly provided by Dr. Jian Du in Dr. Greg
Hannon’s laboratory (Cold Spring Harbor Laboratory, NY). Secondary
antibodies Cy3-conjugated goat anti-mouse and goat anti-rabbit IgG
were purchased from Jackson Immunoresearch Laboratories (West
Grove, PA). Oregon green-conjugated and rhodamine-conjugated phal-
loidins were from Molecular Probes (Eugene, OR). U0126, LY294002,
and Y27632 were from Calbiochem (La Jolla, CA). All tissue culture
reagents were from Invitrogen.
Cell Culture and Retroviral Infection—Normal NIH3T3 cells were
obtained from the Tissue Culture Facility of Cold Spring Harbor Lab-
oratory. Cells were maintained in Dulbecco’s modified Eagle’s medium
containing 10% BCS, 100 units/ml penicillin, and 100 g/ml streptomy-
cin in a humidifier air (5% CO2) atmosphere, at 37 °C. The stable cell
line expressing H-RasV12 was obtained by the following protocol:
pWZL-Hygro H-RasV12 and corresponding empty retroviral vector
were used to transfect the ecotropic packaging cell line  NX. Trans-
fection was performed by the calcium phosphate method. At 72 h
post-transfection, viral supernatants were collected, filtered, and sup-
plemented with 4 g/ml polybrene. The supernatant was then used to
infect NIH3T3 cells. After infection, cells were selected in hygromycin
(50 g/ml) for 14 days.
Plasmids and Transfection—Retroviral pWZL-Hygro H-RasV12 vec-
tor was a generous gift of Yvette Seger in the Hannon laboratory (Cold
Spring Harbor Laboratory). pEGFP-full-length-p21 (amino acids
1–164) and pEGFP-NLS-p21 (amino acids 1–140) were provided by
Dr. Minoru Asada (International Medical Center of Japan). pEGFP-N1-
XAC, expressing wild-type Xenopus cofilin tagged with EGFP at the C
terminus, was kindly provided by James Bamburg (Colorado State
University). For transient transfection, cells were grown at 60–70%
confluency in Dulbecco’s modified Eagle’s medium containing 10% BCS.
Cells were transfected with a total of 2 g of expression vectors per dish,
using LipofectAMINE PLUS reagent (Invitrogen) according to the man-
ufacturer’s protocol. At 24 h post-transfection, cells were split and
plated onto glass coverslips followed by incubation for additional 24 h.
In some cases, cells on the coverslips were treated with Me2SO, U0126,
or LY294002 for various time periods, then the coverslips were har-
vested and processed for immunofluorescence.
Immunofluorescence—Cells grown on glass coverslips were fixed
with 3% paraformaldehyde for 15 min, permeabilized with 0.2% Triton
X-100 for 5 min, then blocked for 30 min with 1% bovine serum albu-
min/phosphate-buffered saline at room temperature. For immunofluo-
rescence, fixed cells were incubated for 1h with mouse monoclonal p21
antibody (Santa Cruz Biotechnology) or monoclonal vinculin antibody
followed by Cy3-conjugated goat anti-mouse IgG for 1 h. To visualize
F-actin, Oregon green, or rhodamine-conjugated phalloidin (1:100) was
diluted in 1% bovine serum albumin/phosphate-buffered saline for
staining. The coverslips were stained with 46-diamidino-2-phenylin-
dole (DAPI), and then mounted using Prolong Antifade (Molecular
Probes). Samples were examined, and pictures were acquired on a Zeiss
Axiophot microscope equipped with a Photometrics Sensys
(Oberkochen, Germany) cooled CCD camera using Openlab 3.1.1 soft-
ware. All photographs were taken at the same magnification.
Immunoprecipitation and Western Blot Analysis—Cell lysates were
prepared as previously described in 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 10% glycerol, 0.5% Nonidet-P40 including protease inhibitor
mixture tablets (Roche Applied Science) (8). The cell lysates were cen-
trifuged at 13,000  g for 20 min, and the supernatant was collected.
Immunoprecipitations were performed for 1 h at 4 °C using polyclonal
anti-ROCK-I antibody. The immunocomplexes were collected with pro-
tein G-Sepharose (Amersham Biosciences) slurry (50% v/v), washed
four times with lysis buffer, and subjected to SDS-PAGE. For Western
blot, control and treated cells were washed with ice-cold phosphate-
buffered saline containing 1 mM sodium orthovanadate before direct
extraction in 2 SDS Laemmli Sample Buffer. Lysates were clarified by
centrifugation (16,000  g for 15 min at 4 °C), and protein concentra-
tions were measured by Bradford assay (Bio-Rad, Hercules, CA). 10 g
of proteins were resolved by SDS-PAGE then transferred to nitrocellu-
lose membrane (Schleicher & Schuell, Keene, NH). The membrane was
blocked for 30 min in 5% nonfat dried milk or 1% bovine serum albumin
in phosphate-buffered saline plus 0.1% Tween 20 and incubated with
primary antibodies for 1 h, followed by incubation with appropriate
horseradish peroxidase-conjugated secondary antibodies for 1 h at room
temperature. Immunoreactive bands were detected by chemilumines-
cence (PerkinElmer Life Sciences).
Rho-GTP Pull-down Assay—Measurement of GTP-bound Rho was
performed using the Rho Activation Assay kit (Upstate Biotechnology),
following the manufacturer’s instructions. Briefly, the RhoA-binding
domain of Rhotekin expressed as a GST fusion protein was used to
affinity precipitate GTP-bound Rho from cells lysed in 50 mM Tris, pH
7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM
NaCl, 10 mM MgCl2, and protease inhibitor mixture (Roche Applied
Science). Precipitated Rho-GTP was then detected by immunoblot
analysis, using a monoclonal anti-RhoA antibody (Santa Cruz
Biotechnology).
RESULTS
Ras Uncouples Rho-GTP from the ROCK/LIMK/Cofilin Path-
way—NIH3T3 fibroblasts have a flat morphology and well-
developed stress fibers, whereas cells transformed by
H-RasV12 are rounded and lack stress fibers (Fig. 1A). RasV12
is known to activate several effector pathways including Raf/
MEK/MAP, phosphatidylinositol 3-kinase (PI3K), and RalGDS
(25–27). To dissect which signaling pathway is necessary for
the prevention of stress fiber formation in Ras-transformed
NIH3T3 cells, we treated Ras-transformed cells with U0126 or
LY294002, which specifically inhibit MEK or PI3K, respec-
tively. We found that the disruption of stress fibers and focal
adhesions observed in Ras-transformed cells were reversed by
treatment with U0126 but not by LY294002 (Fig. 1A). These
observations are in agreement with previous studies that
showed that activation of the MEK-dependent pathway, but
not PI3K, is necessary for disruption of the actin stress fibers
and focal adhesions by oncogenic Ras (23, 24). We also observed
that the restoration of stress fibers and focal adhesions by
U0126 requires ROCK activity, because either dominant neg-
ative ROCK-I or the ROCK inhibitor, Y27632, were able to
prevent stress fiber formation caused by U0126 (data not
shown).
The small GTPase, RhoA, is known to act upstream of ROCK
and induce the formation of stress fibers and focal adhesions
(14). To examine whether the cytoskeletal changes induced by
Ras oncogene were elicited by regulation of RhoA activity, we
measured the levels of Rho-GTP, using an assay that only
captures the active GTP-bound form of the GTPase (28). Al-
though three isoforms of Rho protein were described, we meas-
ured only RhoA-GTP, because neither RhoB nor RhoC were
detectable in NIH3T3 (data not shown). The level of RhoA-GTP
in Ras-transformed cells was higher than that in parental
NIH3T3 (Fig. 1B), but the difference was abolished by U0126,
consistent with the results obtained by others (29) that sus-
tained activation of Raf/MEK/ERK pathway is required for the
activation of RhoA protein. More importantly, these data dem-
onstrate that active RhoA-GTP, despite its increased level, is
no longer coupled via its interaction with ROCK to the forma-
tion of stress fibers in Ras-transformed cells.
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It was previously reported that a MEK-dependent pathway
leads to disorganization of the actin cytoskeleton in Ras-trans-
formed fibroblasts by down-regulation of ROCK-I/II protein
expression (23, 24). In these studies, they showed that the
amount of Rho-GTP in Ras-transformed cells was comparable
to or higher than that of the untransformed control cells.
Therefore, we also compared the levels of ROCK-I/II proteins
between untransformed and Ras-transformed NIH3T3 cells.
No changes in the levels of either ROCK-I or -II proteins were
detected (Fig. 1C). ROCK-I/II can activate LIM kinase, which
in turn phosphorylates cofilin and thereby inhibits its actin-
depolymerizing activity, thus leading to stabilization of stress
fibers (30, 31). To determine if Ras causes any decrease in
phosphorylated cofilin in NIH3T3 cells, we used an antibody
that detects cofilin phosphorylated by LIM kinase at the Ser-3
residue. We found that cofilin phosphorylation was signifi-
cantly decreased by expression of Ras (Fig. 1C). Furthermore,
the level of phosphorylated cofilin was restored following treat-
ment of Ras-transformed cells with the MEK inhibitor (Fig.
1C). These results indicate an alternative mechanism exists,
other than a decrease in ROCK-I/II proteins as previously
reported in Ras-transformed NRK and Swiss 3T3 cells (23, 24),
for uncoupling Rho-GTP from activating Rho kinases.
Elevated Levels of Cytoplasmic p21 Correlates with the Dis-
ruption of Stress Fibers in Ras-transformed Cells—Despite its
implied role as a tumor suppressor, the level of p21 protein is
significantly elevated in many types of human cancer (2). In
agreement with these observations, we found that p21 protein
expression is induced by Ras in NIH3T3 cells (Fig. 2A). This is
consistent with recent studies showing that Ras activates p21
transcription and promotes p21 protein stability via blocking
proteasome-mediated degradation (32, 33). The p21 protein
was decreased in Ras-transformed cells by MEK inhibition in a
time-dependent manner (Fig. 2A). It was completely undetect-
able at 24 h post-treatment of U0126. This demonstrates that
FIG. 1. RhoA-GTP fails to activate Rho kinases in H-RasV12
transformed NIH3T3 cells. Untransformed or Ras-transformed
NIH3T3 cells were cultured overnight. The cells were then treated with
U0126 (25 M), LY294002 (50 M), or Me2SO (DMSO, 0.1% v/v) for 24 h
followed by immunofluorescence or Rho-GTP assay or Western blot. A,
cells were stained for F-actin to visualize the cytoskeleton and vinculin
to visualize focal adhesions using Oregon green-conjugated phalloidin
and anti-vinculin antibody, respectively. All photographs were taken at
the same magnification. B, cell lysates were subjected to the Rho activity
assay and the amount of Rhotekin-bound Rho (active) and total Rho was
analyzed by anti-RhoA antibody. Similar results were obtained in three
independent experiments. C, cell lysates were analyzed to measure the
amounts of ROCK-I, -II, phosphorylated cofililn, and total cofilin by
Western blot (representative of three independent experiments).
FIG. 2. The amount of p21 correlates inversely with the forma-
tion of stress fibers. Parental NIH3T3 and Ras-transformed cells
were grown overnight and then treated with Me2SO (DMSO, 0.1% v/v)
or 25 M U0126 for the indicated times. A, whole cell lysates were
immunoblotted with anti-p21, anti-phosphocofilin, and anti-cofilin an-
tibodies. Western blot for total cofilin was done after membrane strip-
ping. Levels of cofilin phosphorylation were estimated by densitometry
using an image analyzer (AlphaImager 2200 version 5.5 software).
Relative cofilin phosphorylation levels, normalized to total cofilin, are
expressed versus control cells, which are arbitrarily set to 1. Each value
represents the mean  S.D. of three independent experiments. B, cells
grown overnight on coverslips were treated with 0.1% Me2SO or 25 M
U0126 for various time periods as indicated, then fixed and stained with
Oregon green-conjugated phalloidin. C, Ras-transformed cells were
treated with 0.1% Me2SO (DMSO, control) or 25 M U0126 (5 h), then
fixed and stained with phalloidin, DAPI, and anti-p21 antibody.
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the increase in expression of p21 protein in Ras-transformed
cells was dependent on sustained activation of the Raf/MEK/
ERK pathway. Interestingly, the decrease of p21 following
U0126 treatment was temporally associated with the restora-
tion of stress fibers and increase in cofilin phosphorylation (Fig.
2, A and B). These observations suggested an inverse relation-
ship between the concentration of p21 protein and the forma-
tion of stress fibers. Recently, it was reported that p21 is
induced in the cytoplasm during neuronal differentiation and is
involved in blocking Rho-induced actin remodeling leading to
neurite outgrowth (8). To determine if cytoplasmic p21 was
involved in remodeling of the actin cytoskeleton in Ras-trans-
formed NIH3T3 cells, we performed immunofluorescence stain-
ing to determine the localization of p21. We found that in 90%
of Ras-transformed cells p21 exists abundantly in the cyto-
plasm as well as in the nucleus (Fig. 2C), whereas p21 was not
detectable in the majority of asynchronous NIH3T3 cells (data
not shown), which is consistent with our Western blot data
(Fig. 2A). However, the p21 protein became barely detectable in
the cytoplasm of 70% Ras-transformed cells if treated with the
MEK inhibitor for 5 h (Fig. 2C). Concomitant with a decrease in
cytoplasmic p21, at 5 h post-treatment of U0126, there was an
increase in the levels of phosphorylated cofilin, although it was
too early to monitor obvious reassembly of stress fibers (Fig. 2,
A and B). These results suggest that the loss of p21 from the
cytoplasm and restoration of cofilin phosphorylation might be
associated with MEK inhibition-mediated reassembly of stress
fibers.
Cytoplasmic p21 Is Sufficient for the Maintenance of Disor-
ganized Stress Fibers in Ras-transformed Cells—To directly
determine whether the expression of cytoplasmic p21 is suffi-
cient to block stress fiber formation in Ras-transformed cells,
we transfected Ras-transformed cells with either a full-length
p21 or p21 with a deletion in the nuclear localization signal
(NLS). Following 48 h post-transfection, we treated the cells
with U0126 for an additional 24 h, which caused complete loss
in the expression of endogenous p21 but not in that of exoge-
nous p21 (data not shown). Therefore, we could determine if
ectopic expression of NLS-p21 would affect the restoration of
stress fibers by the MEK inhibitor. Ectopic expression of either
NLS-p21 or full-length p21 had no effect on the morphology of
Ras-transformed cells in the absence of U0126 (Fig. 3A). How-
ever, 88% (44/50) of cells expressing the EGFP-NLS-p21 in
the cytoplasm were refractory to the restoration of stress fibers
caused by MEK inhibition, whereas most of cells expressing the
EGFP control or EGFP-full-length p21 in the nucleus failed to
show such a resistance (Fig. 3B). We also observed that exog-
enous p21, but not NLS-p21, relocalized to the nucleus simi-
larly as endogenous p21 following MEK inhibition (Figs. 2C
and 3B), confirming that cytoplasmic p21, but not nuclear,
conferred such a refractory effect. Furthermore, ectopic expres-
sion of NLS-p21, but not full-length p21, was sufficient to
cause disruption of the actin cytoskeleton in 47% (39/83) of
untransformed NIH3T3 cells (Fig. 3C). It is noteworthy that
full-length p21 showed nuclear-specific pattern of expression in
90% of transfectants, implying that p21 is normally localized in
the nucleus under the absence of oncogenic Ras activation.
Collectively, these results suggest that localization of p21 to the
cytoplasm by Ras is involved in reorganization of the actin
cytoskeleton.
In Vivo Interaction of p21Cip1 with ROCK—ROCK is known
to act downstream of Rho to induce stress fiber formation in
fibroblasts (15). In one report, the expression of cytoplasmic
p21 promotes neurite outgrowth in hippocampal neurons by
forming complex with ROCK and inhibiting its activity (8). To
determine whether endogenous p21 physically interacts with
ROCK in vivo, we immunoprecipitated ROCK from Ras-trans-
formed NIH3T3 cells in which p21 is highly expressed. We
found that endogenous p21 was coprecipitated with an anti-
ROCK-I antibody (Fig. 4A), demonstrating that endogenous
p21 forms a complex with ROCK-I in vivo. Next, we sought to
determine whether ectopic expression of cytoplasmic p21 in
NIH3T3 cells could directly interfere with ROCK/LIMK/cofilin
pathway. For this purpose, we measured the level of phospho-
rylation of exogenously expressed cofilin after cotransfecting
EGFP-tagged cofilin in combination with NLS-p21 or con-
trols. The phosphorylation of exogenous EGFP-cofilin was sig-
nificantly reduced by NLS-p21 protein but not by the wild-
type p21 (Fig. 4B). In addition, treatment of a specific ROCK
inhibitor, Y27632 (10 M), effectively blocked the phosphoryl-
ation of EGFP-cofilin, an observation consistent with the no-
tion that endogenous ROCK is an upstream effector mediating
LIM kinase-dependent phosphorylation of exogenous EGFP-
cofilin as well (Fig. 4B). Taken together, these results suggest
that association of p21 with ROCK in the cytoplasm is the
mechanism by which ROCK/LIMK/cofilin pathway is compro-
mised in Ras-transformed cells.
Restoration of Cofilin Phosphorylation by Inhibition of PI3K
Is Not Sufficient for Stress Fiber Formation—There is increas-
FIG. 3. Cytoplasmic p21 is involved in the disruption of stress
fibers. H-RasV12-transformed NIH3T3 (A and B) or control NIH3T3
(C) were transiently transfected with empty-EGFP control, EGFP-full
length p21, and EGFP-NLS-p21 constructs. After 48 h, cells were fixed
without drug treatment (C) or maintained in the absence (A) or pres-
ence (B) of 25 M U0126 for additional 24 h followed by fixation. F-actin
was visualized using rhodamine-conjugated phalloidin (top panels;
A–C). EGFP-expressing cells represent transfectants (bottom panels;
A–C).
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ing evidence that Akt, which acts downstream of PI3K, directly
phosphorylates p21, thereby resulting in the cytoplasmic local-
ization by causing nuclear export and increased stability of p21
in the cytoplasm (6, 34, 35). Therefore, we sought to determine
whether inhibition of PI3K also affects cytoplasmic localization
of p21 in Ras-transformed NIH3T3 cells. Treatment of cells
with LY294002 caused a loss of cytoplasmic p21 within 2 h in
75% (75/100) of cells (Fig. 5A). We also detected, by Western
blot, a decrease in the amount of p21 protein following the
treatment of LY294002 (Fig. 5B). This down-regulation can be
explained in part by proteasome-dependent degradation, be-
cause pretreatment of proteasome inhibitors, such as lactacys-
tin and MG-132, prevented decrease of p21 caused by PI3K
inhibition (data not shown). Furthermore, we found that inhi-
bition of PI3K was also accompanied by the restoration of
cofilin phosphorylation (Fig. 5B). However, inhibition of PI3K
failed to induce reversion of stress fibers and focal adhesions
(Fig. 1A), suggesting that restoration of cofilin phosphorylation
in Ras-transformed cells is not sufficient for the reorganization
of actin cytoskeleton but requires additional factors. See details
under “Discussion.”
DISCUSSION
Previous studies have shown that RhoA is required for Ras-
mediated transformation (36). In the present study, we found
that the level of active RhoA-GTP was increased in Ras-trans-
formed NIH3T3 cells, which is consistent with recent studies
done by others in different types of Ras-transformed cells (24,
29, 37). However, paradoxically, while RhoA is activated, the
formation of stress fibers and focal adhesions is severely com-
promised in Ras-transformed NIH3T3 cells, implying that
RhoA activity is no longer coupled via its interaction with
ROCK to the formation of stress fibers. Previously, it was
proposed that MEK-dependent down-regulation of ROCK-I/II
proteins in Ras-transformed cells may represent a way for
uncoupling Rho-GTP from ROCK (23, 24). However, such a
decrease of ROCK-I/II proteins was not detected in the present
study (Fig. 1C), suggesting that there is another mechanism for
uncoupling RhoA-GTP from activating Rho kinases.
Despite its role as a cell cycle inhibitor, p21 has been shown
to be up-regulated in cell lines transformed by diverse oncop-
roteins as well as in many human cancers (2, 3, 32, 38). The
functional significance of overexpression of p21 in tumorigen-
esis was supported in a study where introduction of antisense
p21 oligodeoxynucleotides into nude mice that had been im-
planted with highly metastatic breast cancer cells resulted in
suppression of tumor growth and angiogenesis, implicating a
novel function of p21 as an oncogenic factor rather than a
tumor suppressor (39). Although the mechanism by which up-
regulation of p21 contributes to tumorigenesis remains un-
clear, one hypothesis is that p21 not only acts as a direct
inhibitor of CDK2 (5, 40), but also functions as a scaffolding
protein for the assembly of active cyclin D-CDK4/6 complex
(41). As a consequence, the pool of increased p21 is sequestered
in cyclin D-CDK4/6 complex thereby allowing increased activ-
ity of cyclin E-CDK2 for cell cycle progression (42). Recent
studies provide evidence that, in addition to its role in regulat-
ing nuclear events, relocalization of p21 from the nucleus to the
cytoplasm in cancer cells may have functions which are unre-
lated to its role as a CDK inhibitor (2, 3). For example, one
clinical study has shown that p21 was predominantly cytoplas-
mic in the majority of breast cancers and it was closely associ-
ated with poor prognosis (11). Subsequent studies demon-
strated that phosphorylation of p21 by Akt leads to the
FIG. 4. Cytoplasmic p21 interacts with ROCK and inhibits co-
filin phosphorylation. A, cell lysates of Ras-transformed cells were
immunoprecipitated with a polyclonal anti-ROCK-I antibody (lane 2) or
preimmune serum (lane 1) as a negative control. Immunocomplexes
were then electrophoresed followed by blotting with anti-ROCK-I (top)
or anti-p21 antibody (bottom). Whole cell lysate from Ras-transformed
cells was used for positive size marker of ROCK-I and p21 (lane 3). B,
NIH3T3 cells were cotransfected with EGFP-cofilin in combination with
empty EGFP or EGFP-full length-p21 or EGFP-NLS-p21 as indicated.
After 30 h, cells were treated with 10 M Y27632 for 5 h. The lysates
were then electrophoresed and blotted with anti-phosphocofilin, anti-
cofilin, and anti-p21 antibodies. FIG. 5. Inhibition of PI3K leading to restoration of cofilin
phosphorylation is not sufficient for stress fiber formation. Pa-
rental NIH3T3 and Ras-transformed cells were grown overnight and
then treated with Me2SO (0.1% v/v) or 50 M LY294002 for the indi-
cated times. A, Ras-transformed cells treated with LY294002 (2 h) were
fixed and stained with Oregon green-conjugated phalloidin, DAPI, and
anti-p21 antibody. B, whole cell lysates were analyzed by Western blot
with anti-p21, anti-phosphocofilin, and anti-cofilin antibodies. Immu-
noblot for total cofilin were performed after membrane stripping. Rel-
ative levels of cofilin phosphorylation were measured by Western blot,
as described in the legend to Fig. 2.
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cytoplasmic accumulation by causing nuclear export and in-
creased stability of p21 in the cytoplasm (6, 34, 35). In agree-
ment with this observation, we detected a complete loss of
cytoplasmic p21 in Ras-transformed NIH3T3 cells within 2 h
following the inhibition of PI3K, an upstream effector of Akt
(Fig. 5A). Furthermore, total p21 proteins was barely detecta-
ble 5 h after PI3K inhibition (Fig. 5B). It was previously shown
that the Raf/MEK/ERK pathway is responsible for the eleva-
tion of p21 mRNA transcription in H-Ras-transformed NIH3T3
cells (33). In agreement with these results, we found that
inhibition of MEK by U0126 resulted in down-regulating the
expression of total p21 protein (Fig. 2A). These decreases in the
p21 protein by either U0126 or LY294002 were prevented when
cells were pretreated with lactacystin or MG-132 (data not
shown), suggesting that the stability of p21 protein is con-
trolled by proteasome-dependent degradation. Collectively,
these results demonstrate that both MEK-dependent and PI3K-
dependent signaling pathways in Ras-transformed cells are
necessary for de novo synthesis of p21, increased stability of
p21 and localization of p21 protein to the cytoplasm (6, 33–35).
Recently, it was reported that cyclin D1 is a critical mediator of
Ras-induced p21 stability (32). In this report, they proposed
that high level of cyclin D1 blocks p21 binding to the C8
subunit of 20 S proteasome, thereby preventing p21 degrada-
tion. We also found that cyclin D1 is highly up-regulated in
Ras-transformed NIH3T3 cells and the increase was abolished
by either U0126 or LY294002 (data not shown).
What might be the functional role of elevated cytoplasmic
p21, other than cell cycle control, in Ras-transformed cells? It
was recently reported that p21, which is induced in the cyto-
plasm during the course of neuronal differentiation, regulates
Rho-induced actin remodeling leading to neurite outgrowth
phenotype (8). Prompted by this finding, we have investigated
if cytoplasmic p21 plays a role in remodeling of the actin cy-
toskeleton in Ras-transformed NIH3T3 cells. To determine
whether elevated cytoplasmic p21 inhibits the ROCK/LIMK/
cofilin pathway, we used an antibody that detects cofilin phos-
phorylation by LIM kinase at Ser-3 residue. Here we demon-
strate that accumulation of p21 lacking the NLS was sufficient
to inhibit cofilin phosphorylation and to block ROCK-depend-
ent formation of stress fibers (Figs. 3C and 4B). As previously
shown by Tanaka et al. (8), we found that endogenous p21 in
Ras-transformed cells forms a complex with ROCK-I in vivo,
suggesting that p21 exerts its effect via binding to ROCK and
inhibiting its downstream signaling (Fig. 4A). On the other
hand, it is noteworthy that even though LY294002 caused
restoration of cofilin phosphorylation (Fig. 5B), which was pre-
vented when ROCK was inhibited by Y27632 (data not shown),
inhibition of PI3K failed to reorganize the actin cytoskeleton
(Fig. 1A). This suggests that restoration of the ROCK/LIMK/
cofilin pathway alone is not sufficient to cause the formation of
stress fibers. Consistent with this hypothesis, forced expres-
sions of constitutively active or wild-type LIMK in Ras-trans-
formed NIH3T3 did not result in restoration of stress fibers
(data not shown). This result contrasts with what has been
observed in Ras-transformed Swiss 3T3 fibroblasts (24), in
which overexpression of LIMK was sufficient to cause the re-
assembly of stress fibers. At present what factors are required
in NIH3T3 cells, in addition to restoration of cofilin phospho-
rylation remains to be determined. One possibility is that ex-
pression of high molecular weight (HMW) tropomyosin (TM).
The expression of HMW TMs has been reported to be sup-
pressed in many transformed cells (43). Consistently, expres-
sion of HMW tropomyosins was barely detectable in Ras-trans-
formed NIH3T3 cells (data not shown). In contrast, however,
tropomyosin levels were not changed in Ras-transformed Swiss
3T3 cells (24). Interestingly, we found that restoration of stress
fibers by MEK inhibition was accompanied by increased ex-
pressions of HMW TMs, TM-1 and TM-2. However, the in-
crease of TMs was not detected when treated with LY294002
(data not shown). These might explain why ectopic expression
of LIMK in Ras-transformed Swiss 3T3 cells was accompanied
by formation of stress fibers (24), but we were unable to detect
stress fiber induction following expression of wild-type or active
LIMK in Ras-transformed NIH-3T3 cells. We also found that
the inhibition of ROCK-dependent signaling either by domi-
nant negative ROCK-I or Y-27632, in Ras-transformed cells,
prevented restoration of stress fibers and focal adhesions
caused by U0126 (data not shown). From these results, we
hypothesize that restoration of ROCK/LIMK/cofilin pathway,
via loss of cytoplasmic p21, is necessary but not sufficient for
the stress fiber formation, and other additional factors, such as
tropomyosins, that were not restored following inhibition of the
PI3K pathway, are required (Fig. 6). Work is currently in
progress to identify these factors.
In addition to a role for cytoplasmic p21, there is increasing
evidence supporting a critical role for cytoplasmic p27Kip1, an-
other CDK inhibitor of Cip/Kip family, in regulation of cy-
toskeletal dynamics (3, 44, 48, 49). p27Kip1 like p21Cip1 can also
be phosphorylated by AKT, which leads to its localization to the
cytoplasm (45–47). In addition to our study and Tanaka and
colleague’s (8) implicating a role of cytoplasmic p21 in actin
remodeling, a role for cytoplasmic p27 in regulating cell motil-
ity has been reported (48). Accordingly, treatment of cells with
hepatocyte growth factor (HGF) signaling resulted in phospho-
rylation on Ser-10 of p27Kip1 coupled with nuclear export of
p27Kip1 to the cytoplasm, where it is required for cell motility
through actin cytoskeletal rearrangement. Interestingly, anal-
ogous to mammalian cells, -factor treatment of yeast cell
causes cytoplasmic localization of Far1 protein, a cyclin-CDK
inhibitor, followed by reorientation of the actin cytoskeleton
and a polarized structure toward its mating partner (48, 49).
Recently, it was reported that an increase of Cdc2 (CDK1) in
prostate cancer cells modulates cell migration via specific as-
sociation with caldesmon, a previously identified substrate of
Cdc2, in membrane ruffles in motile cells (50, 51). Thus, in
addition to the well-characterized functions of CDKs or CDK
inhibitors as cell cycle regulators, they also have a direct role in
the regulation of the actin cytoskeleton.
In conclusion, our studies demonstrate that expression of
FIG. 6. Regulation of the Rho/ROCK/LIMK/cofilin pathway by
p21Cip1 in Ras-transformed cells. Based on our findings and the
work of others (6, 8, 33–35), a model can be proposed. We hypothesize
that transformation of NIH3T3 cells by oncogenic Ras induces sus-
tained activation of both PI3K and MEK-dependent pathways, which
are necessary for the synthesis of p21, relocalization of p21 to the
cytoplasm and increased stability of p21. The cytoplasmic p21 subse-
quently binds to ROCK and inhibits its downstream effector pathway
thereby contributing to the loss of stress fibers. However, other cellular
factors, in addition to restoring the ROCK/LIMK/cofilin pathway are
required to fully restore stress fibers and focal adhesions. See details
under “Discussion.”
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cytoplasmic p21Cip1 is an essential factor in the signaling path-
ways that contribute to Ras-induced actin cytoskeletal remod-
eling. Further characterization of the pathways linking p21Cip1
to actin-mediated cellular functions will be critical to under-
stand the morphological effects of various oncogenes. Finally,
these studies suggest that localization of p21Cip1 to the cyto-
plasm in transformed cells may be involved in pathways that
favor not only cell proliferation, but also cell motility thereby
contributing to invasion and metastasis.
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